May 2013 FDA Recall Propofol by Hospira Inc.
D-887-2013 - Presence of Particulate Matter; single visible particulate was identified during a retain sample inspection identified as stainless steel

This Class II drug recall was voluntarily initiated by Hospira Inc. on May 25, 2013 for the product Propofol. The FDA reported the reason for recall as presence of particulate matter; single visible particulate was identified during a retain sample inspection identified as stainless steel. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-887-2013

Reason for Recall
Presence of Particulate Matter; single visible particulate was identified during a retain sample inspection identified as stainless steel
Initiated
05-25-2013
Reported
08-21-2013
Quantity
94,110 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
65616
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Hospira Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide
Termination Date About Termination Date
Date that FDA officially terminated the recall.
09-18-2014
Product Description About Product Description
Full technical description of the product.
Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 mL, Single patient infusion vial, RX only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-24; Propofol Injectable Emulsion, 500 mg/50 mL, 50 mL, Single patient infusion vial, RX only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-33

Batch or Lot Expiration Information

Lot# Lot 07-950-DJ Exp. Date 1JUL2013, 10-101-DJ Exp. Date 1OCT2013, and 10-102-DJ Exp. Date 1OCT2013

Affected Packages Involved in this Recall

0409-4699-50 Propofol
0409-4699-30 Propofol
0409-4699-53 Propofol
0409-4699-33 Propofol
0409-4699-54 Propofol
0409-4699-24 Propofol
0409-6010-02 Propofol
0409-6010-25 Propofol